COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Press Releases

  • Home/In The News/Press/KRS Global Announces the Immediate Availability of A Lyophilized & Sterile, Compounded L-Asparaginase Preparation

KRS Global Announces the Immediate Availability of A Lyophilized & Sterile, Compounded L-Asparaginase Preparation

Boca Raton, FL: KRS Global Biotechnology (KRS-GBT), FDA Registered Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to reveal it has developed a sterile, lyophilized L-Asparaginase preparation.
Sterile L-Asparaginase Available in Three Different Concentrations

Boca Raton, FL., November 18, 2014 – “What the market demands, KRS Global strives to provide”, says Stephen Duffie, Vice President of Business Development and leader of the KRS veterinary division. “For quite a while veterinarians have been seeking a sterile L-Asparaginase preparation and we sought to fill that need. Look no further, as of today KRS offers sterile, lyophilized L-Asparaginase in 5,000iu, 10,00iu and 12,500iu concentrations. Gone are the days of filtering and refrigeration”

The benefits of a sterile L-Asparaginase preparation are obvious says Duffie. It’s the not so obvious that they will really appreciate. There will no longer be loss due to filtration during reconstitution or administration. This loss occurs when filters are not pre-treated with sterile water before use; and in some cases even when filters are pre-treated some loss may still occurs. Veterinary hospitals also find that space in the refrigerator is a commodity. Now that L-Asparaginase does not need to be refrigerated that valuable space can be used for other cold items. “The cost of shipping will also be driven down for all of our customers since overnight shipping is no longer required and neither will coolers or ice packs.” Duffie says with a smile that everyone should order in bulk now!

Another representative from the company stated, “This is just the beginning for KRS. We have plans, which will be revealed in time that will make waves. Our closed-system technology has only begun to be revealed. Expect more later this year and into the first quarter of 2015. Wherever possible we aim to eliminate human intervention in the preparation process.” KRS Global is an industry leading customized pharmacy that provides sterile and non-sterile compounding services to patients, surgery centers, ophthalmology clinics, veterinarians and hospitals nationwide. KRS is committed to developing quality processes that facilitates the highest level of safety for patients who are recipients of intravenous or oral preparations. KRS also touts the fact that every sterile injectable is tested for potency, endotoxins, and of course sterility before it leaves the facility and that in most cases this can be done with Rapid Scan technology in three hours or less.

Their early registration with the FDA as an out sourcing facility has propelled the company to the forefront of the compounding industry. They strive to be a leader and the example for others to follow with quality control and adherence to cGMP guidelines. They believe their state-of-the-art quality control workflow/processes will allow them to grow together with the needs of their customers and continue to provide the highest quality service and compounded pharmaceuticals.

For more information, contact:
Stephen Duffie, Vice President of Business Development
Phone: 888-242-7996 ext. 365 or 561-886-9725 – direct